Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): Is a clinical benefit still achievable?
Autor: | Carlini, P. *, Frassoldati, A., De Marco, S., Casali, A., Ruggeri, E.M., Nardi, M., Papaldo, P., Fabi, A., Paoloni, F., Cognetti, F. |
---|---|
Zdroj: | In Annals of Oncology November 2001 12(11):1539-1543 |
Databáze: | ScienceDirect |
Externí odkaz: |